Amwill Healthcare IPO Opens for Subscription
Amwill Healthcare Ltd., a company that makes products for skin, launched its Initial Public Offering (IPO) on Wednesday, February 5. The IPO will close on February 7. This is the latest company to join the list of small and medium-sized enterprises (SMEs) going public this month. The company wants to raise Rs 60 crore through this IPO.
Key Details for Investors
The IPO price is between Rs 105 and Rs 111 per share. If you’re a regular investor, you need to apply for at least 1,200 shares, which will cost you at least Rs 1,33,200. Bigshare Services Pvt. is managing the IPO process, and Unistone Capital Pvt. is the lead manager.
How to Apply
Retail investors can apply for the IPO through their trading accounts. The minimum application size is one lot of 1,200 shares. Shares are expected to be listed on the BSE SME platform on February 12.
Subscription Status and Grey Market Premium
As of Wednesday morning, the IPO has been subscribed 0.1 times. The grey market premium (GMP) is Rs 14, suggesting a possible listing gain of around 12.61%. Remember, GMP is unofficial and based on market speculation.
About Amwill Healthcare
Amwill Healthcare develops and markets [[derma-cosmetic]] products. They work with other companies to manufacture and distribute their products, which treat various skin issues like acne, fungal infections, and anti-aging.
Financial Performance
The company’s financials show strong growth. In FY24, their revenue increased to Rs 44.28 crore from Rs 30.28 crore in FY23. Net profit also jumped significantly to Rs 12.54 crore from Rs 3.11 crore.
Use of Funds
Amwill Healthcare plans to use the IPO proceeds for working capital, marketing, and other business-related activities.